Npm1-mutated Acute Myeloid Leukemia

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: Ziftomenib Maintenance Post Allo-HCT [Phase 1]

  A Phase 1 trial evaluating Ziftomenib as maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia (…

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy [Phase 2]

  This clinical trial update reports a Phase 2 study of ziftomenib for patients with NPM1-mutated or KMT2A-rearranged acute myeloid leukemia w…